Home » Topics » Disease categories and therapies » Immune

Immune
RSS

New S1P1/Edg1 agonists developed by Merck scientists

Sep. 2, 2004

Approvable letter for Certican

Sep. 1, 2004

New triptolide derivatives and their use reported by Pharmagenesis researchers

Aug. 30, 2004

Vertex researchers claim two series of heterocyclic inhibitors of JAK3 and other kinases

Aug. 25, 2004

New inhibitors of ICAM-1/LFA-1-mediated cell adhesion and their use

Aug. 24, 2004

BioPort IND accepted for anthrax immunity stimulating molecule

Aug. 23, 2004

Cangene plans new anthrax project

Aug. 18, 2004

Wyeth and Cambridge Antibody Technology claim new anti-PD-1 antibodies

Aug. 17, 2004

BLA submission for Adacel vaccine

Aug. 17, 2004

New immunosuppressants in early development at Sumitomo

Aug. 16, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...